Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4634658
Max Phase: Preclinical
Molecular Formula: C30H23NO10
Molecular Weight: 557.51
Molecule Type: Unknown
Associated Items:
ID: ALA4634658
Max Phase: Preclinical
Molecular Formula: C30H23NO10
Molecular Weight: 557.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(OC)ccc1C4=O
Standard InChI: InChI=1S/C30H23NO10/c1-28(38,26(36)27(37)40-3)30-19-8-6-4-5-7-9-20(33)29(30,41-30)17-13-18(32)21-22(23(17)31-19)25(35)16-12-14(39-2)10-11-15(16)24(21)34/h4-5,10-13,19-20,26,31-33,36,38H,1-3H3/b5-4-/t19-,20+,26-,28+,29-,30+/m0/s1
Standard InChI Key: RSXKWDSDUVYSQA-UMGCSLAASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 557.51 | Molecular Weight (Monoisotopic): 557.1322 | AlogP: 0.16 | #Rotatable Bonds: 4 |
Polar Surface Area: 175.15 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.87 | CX Basic pKa: | CX LogP: 2.26 | CX LogD: 2.24 |
Aromatic Rings: 2 | Heavy Atoms: 41 | QED Weighted: 0.13 | Np Likeness Score: 1.64 |
1. Adhikari A, Teijaro CN, Yan X, Chang CY, Gui C, Liu YC, Crnovcic I, Yang D, Annaval T, Rader C, Shen B.. (2020) Characterization of TnmH as an O-Methyltransferase Revealing Insights into Tiancimycin Biosynthesis and Enabling a Biocatalytic Strategy To Prepare Antibody-Tiancimycin Conjugates., 63 (15): [PMID:32658465] [10.1021/acs.jmedchem.0c00799] |
Source(1):